Atlassian Corporation TEAM | NASDAQ

$215.35 -$13.72 | -5.99%

Company Overview:

Market Cap: $56.42B
PE Ratio: -161.92
52-Week Range: $135.29 - $326.00

6.1 Year Performance Metrics:

Total Return (with DRIP): 103.29% (12.33% / yr)
Total Return (no DRIP): 103.29% (12.33% / yr)
Share Price: 103.29%
TEAM Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

TEAM Earnings, Revenue, Cash & Debt, Shares Outstaning:

TEAM - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
TEAM - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
TEAM - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
TEAM - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
TEAM - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
TEAM - Cash & Debt
14-Day FREE Trial Get Full Access Now!
TEAM - Revenue
14-Day FREE Trial Get Full Access Now!
TEAM Revenue CAGR:1Y: 21.35%2Y: 21.41%5Y: 25.77%10Y: 32.73%
TEAM - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
TEAM EPS CAGR:1Y: 242.42%2Y: 60.86%5Y: -0.83%10Y: 34.64%
TEAM - Net Income
14-Day FREE Trial Get Full Access Now!
TEAM Net Income CAGR:1Y: -54.77%2Y: -56.83%5Y: N/A10Y: N/A
TEAM - EBITDA
14-Day FREE Trial Get Full Access Now!
TEAM EBITDA CAGR:1Y: -22.73%2Y: -54.69%5Y: N/A10Y: N/A
TEAM - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
TEAM Free Cash Flow CAGR:1Y: 20.51%2Y: 52.92%5Y: 10.14%10Y: 29.55%
TEAM - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
TEAM Free Cash Flow / Share CAGR:1Y: 19.34%2Y: 51.37%5Y: 8.67%10Y: 26.68%
TEAM - Gross Profit
14-Day FREE Trial Get Full Access Now!
TEAM Gross Profit CAGR:1Y: 22.85%2Y: 21.80%5Y: 25.40%10Y: 32.56%
TEAM - Expenses
14-Day FREE Trial Get Full Access Now!
TEAM Expenses CAGR:1Y: 75.06%2Y: 52.02%5Y: 5.90%10Y: 0.64%
TEAM - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
TEAM Shares Outstanding CAGR:1Y: 0.98%2Y: 1.03%5Y: 0.80%10Y: 2.27%
TEAM - Share Buybacks
14-Day FREE Trial Get Full Access Now!
TEAM Share Buybacks CAGR:1Y: -31.97%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TEAM - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
TEAM Stock-Based Comp CAGR:1Y: 30.67%2Y: 19.37%5Y: 39.99%10Y: 44.33%
TEAM - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
TEAM Revenue CAGR:1Y: 21.35%2Y: 21.41%5Y: 25.77%10Y: 32.73%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

TEAM - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TEAM Actual Revenue CAGR:1Y: 21.35%2Y: 21.41%5Y: 25.77%10Y: 32.73%
TEAM - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TEAM Actual EPS CAGR:1Y: 242.42%2Y: 60.86%5Y: -0.83%10Y: 34.64%
TEAM - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TEAM Actual Net Income CAGR:1Y: -54.77%2Y: -56.83%5Y: N/A10Y: N/A
TEAM - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TEAM Actual EBITDA CAGR:1Y: -22.73%2Y: -54.69%5Y: N/A10Y: N/A

Ratios, Profit Margins & Return on Capital:

TEAM - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
TEAM Net Profit Margin CAGR:1Y: -62.74%2Y: -64.44%5Y: N/A10Y: N/A
TEAM - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
TEAM Gross Profit Margin CAGR:1Y: 1.24%2Y: 0.32%5Y: -0.30%10Y: -0.13%
TEAM - Price to Earnings
14-Day FREE Trial Get Full Access Now!
TEAM - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
TEAM - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
TEAM - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for TEAM

Based on past 6.1-year performance, here are TEAM growth metrics:

Share price CAGR of +12.33%
Dividend CAGR of +0%

Using TEAM CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

TEAM (DRIP)TEAM - No DRIP
Current Price$229.07$229.07
Start Shares43.6543.65
Start Value$10,000$10,000
  
After 10 years:
Final Share Count43.6543.65
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$652.49$229.07
Total Dividends$0$0
Final Value$28,484$10,000

Estimated Future Value + Dividends - TEAM

NOTE: Above numbers are our estimate based on TEAM's Dividend and Price CAGR over past 6.1 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Atlassian Corporation (TEAM) had its IPO on , and is trader on NASDAQ stock exchange.

TEAM website: https://www.atlassian.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial